3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Hemophilia A
1
Interventions
Cisplatin
187
Carboplatin
182
Paclitaxel
178
Docetaxel
146
Cyclophosphamide
129
Dexamethasone
118
pembrolizumab
106
Bevacizumab
104
Doxorubicin
103
Gemcitabine
102
Rituximab
96
Prednisone
87
Fluorouracil
86
Pemetrexed
82
Radiotherapy
77
Vincristine
71
Etoposide
71
Nivolumab
69
Capecitabine
69
Trastuzumab
67
Leucovorin
64
Cytarabine
57
Methotrexate
52
Oxaliplatin
49
atezolizumab
48
Lenalidomide
43
Ipilimumab
40
Filgrastim
40
Bortezomib
39
Sorafenib
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Has results
×
recombinant FVIIa
×
Clear all
NCT02622321
2021-06-24
HAVEN 1
Hoffmann-La Roche
Phase 3
Completed
113 enrolled
45 charts
1 FDA